Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 66

Results For "SEC"

3686 News Found

Evonik bets €80 million on biotech expansion to power next-gen pharma growth
Biotech | April 23, 2026

Evonik bets €80 million on biotech expansion to power next-gen pharma growth

The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances


Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes
R&D | April 23, 2026

Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes

Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport


India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation
News | April 23, 2026

India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation

New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements


PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem
Digitisation | April 23, 2026

PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem

Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing


Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA
Drug Approval | April 23, 2026

Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA

The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling


New guardian protein mechanism identified in aggressive skin cancer progression
R&D | April 22, 2026

New guardian protein mechanism identified in aggressive skin cancer progression

While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies


ECI taps industry veteran Khalid Raja to drive strategic growth
People | April 22, 2026

ECI taps industry veteran Khalid Raja to drive strategic growth

Move comes amid rising regulatory pressures


Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform


Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
Clinical Trials | April 22, 2026

Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion

If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev


Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion
News | April 22, 2026

Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion

A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline